Segui
Steven G. Gray
Steven G. Gray
St James's Hospital & Trinity College Dublin
Email verificata su stjames.ie - Home page
Titolo
Citata da
Citata da
Anno
The human histone deacetylase family
SG Gray, TJ Ekström
Experimental cell research 262 (2), 75-83, 2001
7882001
circular RNAs: biogenesis, function and role in human diseases
J Greene, AM Baird, L Brady, M Lim, SG Gray, R McDermott, SP Finn
Frontiers in Molecular Biosciences 4, 2017
5362017
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
S Camelo, AH Iglesias, D Hwang, B Due, H Ryu, K Smith, SG Gray, ...
Journal of neuroimmunology 164 (1), 10-21, 2005
3362005
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature
MP Barr, SG Gray, AC Hoffmann, RA Hilger, J Thomale, JD O’Flaherty, ...
PloS one 8 (1), e54193, 2013
3282013
Molecular subclassification of kidney tumors and the discovery of new diagnostic markers
M Takahashi, XJ Yang, J Sugimura, J Backdahl, M Tretiakova, CN Qian, ...
Oncogene 22 (43), 6810-6818, 2003
2482003
Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer
JD O’Flaherty, S Gray, D Richard, D Fennell, JJ O’Leary, FH Blackhall, ...
Lung Cancer 76 (1), 19-25, 2012
2142012
NF‐κB regulation: the nuclear response
AK Mankan, MW Lawless, SG Gray, D Kelleher, R McManus
Journal of cellular and molecular medicine 13 (4), 631-643, 2009
2102009
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells
R Heery, SP Finn, S Cuffe, SG Gray
Cancers 9 (4), 38, 2017
1972017
Lung cancer stem cells: The root of resistance
L MacDonagh, SG Gray, E Breen, S Cuffe, SP Finn, KJ O'Byrne, MP Barr
Cancer Letters, 2016
1712016
Role of histone and transcription factor acetylation in diabetes pathogenesis
SG Gray, P De Meyts
Diabetes/metabolism research and reviews 21 (5), 416-433, 2005
1662005
Functional characterization of JMJD2A, a histone deacetylase-and retinoblastoma-binding protein
SG Gray, AH Iglesias, F Lizcano, R Villanueva, S Camelo, H Jingu, ...
Journal of Biological Chemistry 280 (31), 28507-28518, 2005
1632005
The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer
A Chellamuthu, SG Gray
Cells 9 (8), 1758, 2020
1492020
Genotyping of Adrenocortical Tumors: Very Frequent Deletions of the MEN1 Locus in 11q13 and of a 1-Centimorgan Region in 2p16 1
M Kjellman, L Roshani, BT Teh, OP Kallioniemi, A Höög, S Gray, ...
The Journal of Clinical Endocrinology & Metabolism 84 (2), 730-735, 1999
1341999
Histone acetylation/deacetylation and cancer: an “open” and “shut” case?
SG Gray, BT Teh
Current molecular medicine 1 (4), 401-429, 2001
1262001
Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis
SG Gray, F Dangond
Epigenetics 1 (2), 67-75, 2006
1242006
Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy
MW Lawless, KJ O’Byrne, SG Gray
Journal of cellular and molecular medicine 13 (9a), 2800-2821, 2009
1232009
The emerging role of microRNAs in resistance to lung cancer treatments
L MacDonagh, SG Gray, SP Finn, S Cuffe, KJ O’Byrne, MP Barr
Cancer treatment reviews 41 (2), 160-169, 2015
1122015
Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines
SG Gray, CN Qian, K Furge, X Guo, BT Teh
International journal of oncology 24 (4), 773-795, 2004
1092004
Receptor tyrosine kinases and their activation in melanoma
DJ Easty, SG Gray, KJ O’Byrne, D O’Donnell, DC Bennett
Pigment cell & melanoma research 24 (3), 446-461, 2011
1032011
BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC
L MacDonagh, SG Gray, E Breen, S Cuffe, SP Finn, KJ O'Byrne, MP Barr
Cancer letters 428, 117-126, 2018
872018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20